PubMed for id: 469609

Year	Number of Results
1993	2
1995	1
1996	5
1997	2
1998	2
1999	7
2000	6
2001	7
2002	4
2003	9
2004	11
2005	13
2006	18
2007	20
2008	8
2009	13
2010	12
2011	10
2012	2
2024	0

1

The interaction of PKN3 with RhoC promotes malignant growth.

Unsal-Kacmaz K, Ragunathan S, Rosfjord E, Dann S, Upeslacis E, Grillo M, Hernandez R, Mack F, Klippel A. Unsal-Kacmaz K, et al. Mol Oncol. 2012 Jun;6(3):284-98. doi: 10.1016/j.molonc.2011.12.001. Epub 2011 Dec 28. Mol Oncol. 2012. PMID: 22217540 Free PMC article.

2

Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors.

Strumberg D, Schultheis B, Traugott U, Vank C, Santel A, Keil O, Giese K, Kaufmann J, Drevs J. Strumberg D, et al. Int J Clin Pharmacol Ther. 2012 Jan;50(1):76-8. doi: 10.5414/cpp50076. Int J Clin Pharmacol Ther. 2012. PMID: 22192654 Free article. Clinical Trial. No abstract available.

3

Rho kinase as a therapeutic target in cardiovascular disease.

Surma M, Wei L, Shi J. Surma M, et al. Future Cardiol. 2011 Sep;7(5):657-71. doi: 10.2217/fca.11.51. Future Cardiol. 2011. PMID: 21929346 Free PMC article. Review.

4

The F-BAR protein Rapostlin regulates dendritic spine formation in hippocampal neurons.

Wakita Y, Kakimoto T, Katoh H, Negishi M. Wakita Y, et al. J Biol Chem. 2011 Sep 16;286(37):32672-83. doi: 10.1074/jbc.M111.236265. Epub 2011 Jul 15. J Biol Chem. 2011. PMID: 21768103 Free PMC article.

5

Regulatory domain selectivity in the cell-type specific PKN-dependence of cell migration.

Lachmann S, Jevons A, De Rycker M, Casamassima A, Radtke S, Collazos A, Parker PJ. Lachmann S, et al. PLoS One. 2011;6(7):e21732. doi: 10.1371/journal.pone.0021732. Epub 2011 Jul 6. PLoS One. 2011. PMID: 21754995 Free PMC article.

6

Site recognition and substrate screens for PKN family proteins.

Collazos A, Michael N, Whelan RD, Kelly G, Mellor H, Pang LC, Totty N, Parker PJ. Collazos A, et al. Biochem J. 2011 Sep 15;438(3):535-43. doi: 10.1042/BJ20110521. Biochem J. 2011. PMID: 21749319

7

Requirement for FBP17 in invadopodia formation by invasive bladder tumor cells.

Yamamoto H, Sutoh M, Hatakeyama S, Hashimoto Y, Yoneyama T, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S. Yamamoto H, et al. J Urol. 2011 May;185(5):1930-8. doi: 10.1016/j.juro.2010.12.027. Epub 2011 Mar 21. J Urol. 2011. PMID: 21421245

8

Mutational analysis reveals a single binding interface between RhoA and its effector, PRK1.

Hutchinson CL, Lowe PN, McLaughlin SH, Mott HR, Owen D. Hutchinson CL, et al. Biochemistry. 2011 Apr 12;50(14):2860-9. doi: 10.1021/bi200039u. Epub 2011 Mar 16. Biochemistry. 2011. PMID: 21351730

9

Rho-kinase in development and heart failure: insights from genetic models.

Shi J, Zhang L, Wei L. Shi J, et al. Pediatr Cardiol. 2011 Mar;32(3):297-304. doi: 10.1007/s00246-011-9920-0. Epub 2011 Feb 16. Pediatr Cardiol. 2011. PMID: 21327630 Free PMC article. Review.

10

Hypotonic swelling-induced activation of PKN1 mediates cell survival in cardiac myocytes.

Kajimoto K, Shao D, Takagi H, Maceri G, Zablocki D, Mukai H, Ono Y, Sadoshima J. Kajimoto K, et al. Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H191-200. doi: 10.1152/ajpheart.00232.2010. Epub 2010 Oct 29. Am J Physiol Heart Circ Physiol. 2011. PMID: 21037231 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

143 results

Results by year